Global RNAi for Therapeutic Market Research Report 2024(Status and Outlook)
Report Overview
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
This report provides a deep insight into the global RNAi for Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNAi for Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNAi for Therapeutic market in any manner.
Global RNAi for Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market Segmentation (by Type)
siRNA
miRNA
shRNA
Market Segmentation (by Application)
Cancer
Cardiovascular
HBV
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNAi for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
This report provides a deep insight into the global RNAi for Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNAi for Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNAi for Therapeutic market in any manner.
Global RNAi for Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market Segmentation (by Type)
siRNA
miRNA
shRNA
Market Segmentation (by Application)
Cancer
Cardiovascular
HBV
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the RNAi for Therapeutic Market
- Overview of the regional outlook of the RNAi for Therapeutic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNAi for Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of RNAi for Therapeutic
1.2 Key Market Segments
1.2.1 RNAi for Therapeutic Segment by Type
1.2.2 RNAi for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNAI FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNAi for Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNAi for Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNAI FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global RNAi for Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global RNAi for Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNAi for Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNAi for Therapeutic Sales Sites, Area Served, Product Type
3.6 RNAi for Therapeutic Market Competitive Situation and Trends
3.6.1 RNAi for Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNAi for Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNAI FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 RNAi for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNAI FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNAi for Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global RNAi for Therapeutic Price by Type (2019-2024)
7 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNAi for Therapeutic Market Sales by Application (2019-2024)
7.3 Global RNAi for Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
8 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global RNAi for Therapeutic Sales by Region
8.1.1 Global RNAi for Therapeutic Sales by Region
8.1.2 Global RNAi for Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America RNAi for Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNAi for Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNAi for Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNAi for Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNAi for Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam Pharmaceuticals
9.1.1 Alnylam Pharmaceuticals RNAi for Therapeutic Basic Information
9.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Product Overview
9.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.1.4 Alnylam Pharmaceuticals Business Overview
9.1.5 Alnylam Pharmaceuticals RNAi for Therapeutic SWOT Analysis
9.1.6 Alnylam Pharmaceuticals Recent Developments
9.2 Arbutus Biopharma (Tekmira)
9.2.1 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Basic Information
9.2.2 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Overview
9.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Market Performance
9.2.4 Arbutus Biopharma (Tekmira) Business Overview
9.2.5 Arbutus Biopharma (Tekmira) RNAi for Therapeutic SWOT Analysis
9.2.6 Arbutus Biopharma (Tekmira) Recent Developments
9.3 Arrowhead
9.3.1 Arrowhead RNAi for Therapeutic Basic Information
9.3.2 Arrowhead RNAi for Therapeutic Product Overview
9.3.3 Arrowhead RNAi for Therapeutic Product Market Performance
9.3.4 Arrowhead RNAi for Therapeutic SWOT Analysis
9.3.5 Arrowhead Business Overview
9.3.6 Arrowhead Recent Developments
9.4 Dicerna Pharmaceuticals
9.4.1 Dicerna Pharmaceuticals RNAi for Therapeutic Basic Information
9.4.2 Dicerna Pharmaceuticals RNAi for Therapeutic Product Overview
9.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.4.4 Dicerna Pharmaceuticals Business Overview
9.4.5 Dicerna Pharmaceuticals Recent Developments
9.5 Mirna Therapeutics
9.5.1 Mirna Therapeutics RNAi for Therapeutic Basic Information
9.5.2 Mirna Therapeutics RNAi for Therapeutic Product Overview
9.5.3 Mirna Therapeutics RNAi for Therapeutic Product Market Performance
9.5.4 Mirna Therapeutics Business Overview
9.5.5 Mirna Therapeutics Recent Developments
9.6 Quark Pharmaceuticals
9.6.1 Quark Pharmaceuticals RNAi for Therapeutic Basic Information
9.6.2 Quark Pharmaceuticals RNAi for Therapeutic Product Overview
9.6.3 Quark Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.6.4 Quark Pharmaceuticals Business Overview
9.6.5 Quark Pharmaceuticals Recent Developments
9.7 RXi Pharmaceuticals
9.7.1 RXi Pharmaceuticals RNAi for Therapeutic Basic Information
9.7.2 RXi Pharmaceuticals RNAi for Therapeutic Product Overview
9.7.3 RXi Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.7.4 RXi Pharmaceuticals Business Overview
9.7.5 RXi Pharmaceuticals Recent Developments
9.8 Silence Therapeutics
9.8.1 Silence Therapeutics RNAi for Therapeutic Basic Information
9.8.2 Silence Therapeutics RNAi for Therapeutic Product Overview
9.8.3 Silence Therapeutics RNAi for Therapeutic Product Market Performance
9.8.4 Silence Therapeutics Business Overview
9.8.5 Silence Therapeutics Recent Developments
9.9 Benitec Biopharma
9.9.1 Benitec Biopharma RNAi for Therapeutic Basic Information
9.9.2 Benitec Biopharma RNAi for Therapeutic Product Overview
9.9.3 Benitec Biopharma RNAi for Therapeutic Product Market Performance
9.9.4 Benitec Biopharma Business Overview
9.9.5 Benitec Biopharma Recent Developments
9.10 miRagen Therapeutics
9.10.1 miRagen Therapeutics RNAi for Therapeutic Basic Information
9.10.2 miRagen Therapeutics RNAi for Therapeutic Product Overview
9.10.3 miRagen Therapeutics RNAi for Therapeutic Product Market Performance
9.10.4 miRagen Therapeutics Business Overview
9.10.5 miRagen Therapeutics Recent Developments
9.11 Sylentis
9.11.1 Sylentis RNAi for Therapeutic Basic Information
9.11.2 Sylentis RNAi for Therapeutic Product Overview
9.11.3 Sylentis RNAi for Therapeutic Product Market Performance
9.11.4 Sylentis Business Overview
9.11.5 Sylentis Recent Developments
9.12 Gradalis
9.12.1 Gradalis RNAi for Therapeutic Basic Information
9.12.2 Gradalis RNAi for Therapeutic Product Overview
9.12.3 Gradalis RNAi for Therapeutic Product Market Performance
9.12.4 Gradalis Business Overview
9.12.5 Gradalis Recent Developments
9.13 Sirnaomics
9.13.1 Sirnaomics RNAi for Therapeutic Basic Information
9.13.2 Sirnaomics RNAi for Therapeutic Product Overview
9.13.3 Sirnaomics RNAi for Therapeutic Product Market Performance
9.13.4 Sirnaomics Business Overview
9.13.5 Sirnaomics Recent Developments
9.14 Silenseed
9.14.1 Silenseed RNAi for Therapeutic Basic Information
9.14.2 Silenseed RNAi for Therapeutic Product Overview
9.14.3 Silenseed RNAi for Therapeutic Product Market Performance
9.14.4 Silenseed Business Overview
9.14.5 Silenseed Recent Developments
10 RNAI FOR THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global RNAi for Therapeutic Market Size Forecast
10.2 Global RNAi for Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNAi for Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific RNAi for Therapeutic Market Size Forecast by Region
10.2.4 South America RNAi for Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNAi for Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNAi for Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNAi for Therapeutic by Type (2025-2030)
11.1.2 Global RNAi for Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNAi for Therapeutic by Type (2025-2030)
11.2 Global RNAi for Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global RNAi for Therapeutic Sales (K Units) Forecast by Application
11.2.2 Global RNAi for Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of RNAi for Therapeutic
1.2 Key Market Segments
1.2.1 RNAi for Therapeutic Segment by Type
1.2.2 RNAi for Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNAI FOR THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RNAi for Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global RNAi for Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNAI FOR THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global RNAi for Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global RNAi for Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNAi for Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers RNAi for Therapeutic Sales Sites, Area Served, Product Type
3.6 RNAi for Therapeutic Market Competitive Situation and Trends
3.6.1 RNAi for Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNAi for Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNAI FOR THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 RNAi for Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RNAI FOR THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNAi for Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global RNAi for Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global RNAi for Therapeutic Price by Type (2019-2024)
7 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNAi for Therapeutic Market Sales by Application (2019-2024)
7.3 Global RNAi for Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
8 RNAI FOR THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global RNAi for Therapeutic Sales by Region
8.1.1 Global RNAi for Therapeutic Sales by Region
8.1.2 Global RNAi for Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America RNAi for Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNAi for Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNAi for Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNAi for Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNAi for Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam Pharmaceuticals
9.1.1 Alnylam Pharmaceuticals RNAi for Therapeutic Basic Information
9.1.2 Alnylam Pharmaceuticals RNAi for Therapeutic Product Overview
9.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.1.4 Alnylam Pharmaceuticals Business Overview
9.1.5 Alnylam Pharmaceuticals RNAi for Therapeutic SWOT Analysis
9.1.6 Alnylam Pharmaceuticals Recent Developments
9.2 Arbutus Biopharma (Tekmira)
9.2.1 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Basic Information
9.2.2 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Overview
9.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Market Performance
9.2.4 Arbutus Biopharma (Tekmira) Business Overview
9.2.5 Arbutus Biopharma (Tekmira) RNAi for Therapeutic SWOT Analysis
9.2.6 Arbutus Biopharma (Tekmira) Recent Developments
9.3 Arrowhead
9.3.1 Arrowhead RNAi for Therapeutic Basic Information
9.3.2 Arrowhead RNAi for Therapeutic Product Overview
9.3.3 Arrowhead RNAi for Therapeutic Product Market Performance
9.3.4 Arrowhead RNAi for Therapeutic SWOT Analysis
9.3.5 Arrowhead Business Overview
9.3.6 Arrowhead Recent Developments
9.4 Dicerna Pharmaceuticals
9.4.1 Dicerna Pharmaceuticals RNAi for Therapeutic Basic Information
9.4.2 Dicerna Pharmaceuticals RNAi for Therapeutic Product Overview
9.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.4.4 Dicerna Pharmaceuticals Business Overview
9.4.5 Dicerna Pharmaceuticals Recent Developments
9.5 Mirna Therapeutics
9.5.1 Mirna Therapeutics RNAi for Therapeutic Basic Information
9.5.2 Mirna Therapeutics RNAi for Therapeutic Product Overview
9.5.3 Mirna Therapeutics RNAi for Therapeutic Product Market Performance
9.5.4 Mirna Therapeutics Business Overview
9.5.5 Mirna Therapeutics Recent Developments
9.6 Quark Pharmaceuticals
9.6.1 Quark Pharmaceuticals RNAi for Therapeutic Basic Information
9.6.2 Quark Pharmaceuticals RNAi for Therapeutic Product Overview
9.6.3 Quark Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.6.4 Quark Pharmaceuticals Business Overview
9.6.5 Quark Pharmaceuticals Recent Developments
9.7 RXi Pharmaceuticals
9.7.1 RXi Pharmaceuticals RNAi for Therapeutic Basic Information
9.7.2 RXi Pharmaceuticals RNAi for Therapeutic Product Overview
9.7.3 RXi Pharmaceuticals RNAi for Therapeutic Product Market Performance
9.7.4 RXi Pharmaceuticals Business Overview
9.7.5 RXi Pharmaceuticals Recent Developments
9.8 Silence Therapeutics
9.8.1 Silence Therapeutics RNAi for Therapeutic Basic Information
9.8.2 Silence Therapeutics RNAi for Therapeutic Product Overview
9.8.3 Silence Therapeutics RNAi for Therapeutic Product Market Performance
9.8.4 Silence Therapeutics Business Overview
9.8.5 Silence Therapeutics Recent Developments
9.9 Benitec Biopharma
9.9.1 Benitec Biopharma RNAi for Therapeutic Basic Information
9.9.2 Benitec Biopharma RNAi for Therapeutic Product Overview
9.9.3 Benitec Biopharma RNAi for Therapeutic Product Market Performance
9.9.4 Benitec Biopharma Business Overview
9.9.5 Benitec Biopharma Recent Developments
9.10 miRagen Therapeutics
9.10.1 miRagen Therapeutics RNAi for Therapeutic Basic Information
9.10.2 miRagen Therapeutics RNAi for Therapeutic Product Overview
9.10.3 miRagen Therapeutics RNAi for Therapeutic Product Market Performance
9.10.4 miRagen Therapeutics Business Overview
9.10.5 miRagen Therapeutics Recent Developments
9.11 Sylentis
9.11.1 Sylentis RNAi for Therapeutic Basic Information
9.11.2 Sylentis RNAi for Therapeutic Product Overview
9.11.3 Sylentis RNAi for Therapeutic Product Market Performance
9.11.4 Sylentis Business Overview
9.11.5 Sylentis Recent Developments
9.12 Gradalis
9.12.1 Gradalis RNAi for Therapeutic Basic Information
9.12.2 Gradalis RNAi for Therapeutic Product Overview
9.12.3 Gradalis RNAi for Therapeutic Product Market Performance
9.12.4 Gradalis Business Overview
9.12.5 Gradalis Recent Developments
9.13 Sirnaomics
9.13.1 Sirnaomics RNAi for Therapeutic Basic Information
9.13.2 Sirnaomics RNAi for Therapeutic Product Overview
9.13.3 Sirnaomics RNAi for Therapeutic Product Market Performance
9.13.4 Sirnaomics Business Overview
9.13.5 Sirnaomics Recent Developments
9.14 Silenseed
9.14.1 Silenseed RNAi for Therapeutic Basic Information
9.14.2 Silenseed RNAi for Therapeutic Product Overview
9.14.3 Silenseed RNAi for Therapeutic Product Market Performance
9.14.4 Silenseed Business Overview
9.14.5 Silenseed Recent Developments
10 RNAI FOR THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global RNAi for Therapeutic Market Size Forecast
10.2 Global RNAi for Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe RNAi for Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific RNAi for Therapeutic Market Size Forecast by Region
10.2.4 South America RNAi for Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of RNAi for Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global RNAi for Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of RNAi for Therapeutic by Type (2025-2030)
11.1.2 Global RNAi for Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of RNAi for Therapeutic by Type (2025-2030)
11.2 Global RNAi for Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global RNAi for Therapeutic Sales (K Units) Forecast by Application
11.2.2 Global RNAi for Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNAi for Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global RNAi for Therapeutic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global RNAi for Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNAi for Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNAi for Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi for Therapeutic as of 2022)
Table 10. Global Market RNAi for Therapeutic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNAi for Therapeutic Sales Sites and Area Served
Table 12. Manufacturers RNAi for Therapeutic Product Type
Table 13. Global RNAi for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNAi for Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNAi for Therapeutic Market Challenges
Table 22. Global RNAi for Therapeutic Sales by Type (K Units)
Table 23. Global RNAi for Therapeutic Market Size by Type (M USD)
Table 24. Global RNAi for Therapeutic Sales (K Units) by Type (2019-2024)
Table 25. Global RNAi for Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global RNAi for Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global RNAi for Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global RNAi for Therapeutic Price (USD/Unit) by Type (2019-2024)
Table 29. Global RNAi for Therapeutic Sales (K Units) by Application
Table 30. Global RNAi for Therapeutic Market Size by Application
Table 31. Global RNAi for Therapeutic Sales by Application (2019-2024) & (K Units)
Table 32. Global RNAi for Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global RNAi for Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global RNAi for Therapeutic Market Share by Application (2019-2024)
Table 35. Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 37. Global RNAi for Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 39. Europe RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 41. South America RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 43. Alnylam Pharmaceuticals RNAi for Therapeutic Basic Information
Table 44. Alnylam Pharmaceuticals RNAi for Therapeutic Product Overview
Table 45. Alnylam Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Alnylam Pharmaceuticals Business Overview
Table 47. Alnylam Pharmaceuticals RNAi for Therapeutic SWOT Analysis
Table 48. Alnylam Pharmaceuticals Recent Developments
Table 49. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Basic Information
Table 50. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Overview
Table 51. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Arbutus Biopharma (Tekmira) Business Overview
Table 53. Arbutus Biopharma (Tekmira) RNAi for Therapeutic SWOT Analysis
Table 54. Arbutus Biopharma (Tekmira) Recent Developments
Table 55. Arrowhead RNAi for Therapeutic Basic Information
Table 56. Arrowhead RNAi for Therapeutic Product Overview
Table 57. Arrowhead RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Arrowhead RNAi for Therapeutic SWOT Analysis
Table 59. Arrowhead Business Overview
Table 60. Arrowhead Recent Developments
Table 61. Dicerna Pharmaceuticals RNAi for Therapeutic Basic Information
Table 62. Dicerna Pharmaceuticals RNAi for Therapeutic Product Overview
Table 63. Dicerna Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dicerna Pharmaceuticals Business Overview
Table 65. Dicerna Pharmaceuticals Recent Developments
Table 66. Mirna Therapeutics RNAi for Therapeutic Basic Information
Table 67. Mirna Therapeutics RNAi for Therapeutic Product Overview
Table 68. Mirna Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mirna Therapeutics Business Overview
Table 70. Mirna Therapeutics Recent Developments
Table 71. Quark Pharmaceuticals RNAi for Therapeutic Basic Information
Table 72. Quark Pharmaceuticals RNAi for Therapeutic Product Overview
Table 73. Quark Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Quark Pharmaceuticals Business Overview
Table 75. Quark Pharmaceuticals Recent Developments
Table 76. RXi Pharmaceuticals RNAi for Therapeutic Basic Information
Table 77. RXi Pharmaceuticals RNAi for Therapeutic Product Overview
Table 78. RXi Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. RXi Pharmaceuticals Business Overview
Table 80. RXi Pharmaceuticals Recent Developments
Table 81. Silence Therapeutics RNAi for Therapeutic Basic Information
Table 82. Silence Therapeutics RNAi for Therapeutic Product Overview
Table 83. Silence Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Silence Therapeutics Business Overview
Table 85. Silence Therapeutics Recent Developments
Table 86. Benitec Biopharma RNAi for Therapeutic Basic Information
Table 87. Benitec Biopharma RNAi for Therapeutic Product Overview
Table 88. Benitec Biopharma RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Benitec Biopharma Business Overview
Table 90. Benitec Biopharma Recent Developments
Table 91. miRagen Therapeutics RNAi for Therapeutic Basic Information
Table 92. miRagen Therapeutics RNAi for Therapeutic Product Overview
Table 93. miRagen Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. miRagen Therapeutics Business Overview
Table 95. miRagen Therapeutics Recent Developments
Table 96. Sylentis RNAi for Therapeutic Basic Information
Table 97. Sylentis RNAi for Therapeutic Product Overview
Table 98. Sylentis RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sylentis Business Overview
Table 100. Sylentis Recent Developments
Table 101. Gradalis RNAi for Therapeutic Basic Information
Table 102. Gradalis RNAi for Therapeutic Product Overview
Table 103. Gradalis RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Gradalis Business Overview
Table 105. Gradalis Recent Developments
Table 106. Sirnaomics RNAi for Therapeutic Basic Information
Table 107. Sirnaomics RNAi for Therapeutic Product Overview
Table 108. Sirnaomics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sirnaomics Business Overview
Table 110. Sirnaomics Recent Developments
Table 111. Silenseed RNAi for Therapeutic Basic Information
Table 112. Silenseed RNAi for Therapeutic Product Overview
Table 113. Silenseed RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Silenseed Business Overview
Table 115. Silenseed Recent Developments
Table 116. Global RNAi for Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global RNAi for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific RNAi for Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific RNAi for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa RNAi for Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global RNAi for Therapeutic Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global RNAi for Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global RNAi for Therapeutic Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global RNAi for Therapeutic Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global RNAi for Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNAi for Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global RNAi for Therapeutic Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global RNAi for Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global RNAi for Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global RNAi for Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi for Therapeutic as of 2022)
Table 10. Global Market RNAi for Therapeutic Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers RNAi for Therapeutic Sales Sites and Area Served
Table 12. Manufacturers RNAi for Therapeutic Product Type
Table 13. Global RNAi for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNAi for Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNAi for Therapeutic Market Challenges
Table 22. Global RNAi for Therapeutic Sales by Type (K Units)
Table 23. Global RNAi for Therapeutic Market Size by Type (M USD)
Table 24. Global RNAi for Therapeutic Sales (K Units) by Type (2019-2024)
Table 25. Global RNAi for Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global RNAi for Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global RNAi for Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global RNAi for Therapeutic Price (USD/Unit) by Type (2019-2024)
Table 29. Global RNAi for Therapeutic Sales (K Units) by Application
Table 30. Global RNAi for Therapeutic Market Size by Application
Table 31. Global RNAi for Therapeutic Sales by Application (2019-2024) & (K Units)
Table 32. Global RNAi for Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global RNAi for Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global RNAi for Therapeutic Market Share by Application (2019-2024)
Table 35. Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 37. Global RNAi for Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 39. Europe RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 41. South America RNAi for Therapeutic Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa RNAi for Therapeutic Sales by Region (2019-2024) & (K Units)
Table 43. Alnylam Pharmaceuticals RNAi for Therapeutic Basic Information
Table 44. Alnylam Pharmaceuticals RNAi for Therapeutic Product Overview
Table 45. Alnylam Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Alnylam Pharmaceuticals Business Overview
Table 47. Alnylam Pharmaceuticals RNAi for Therapeutic SWOT Analysis
Table 48. Alnylam Pharmaceuticals Recent Developments
Table 49. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Basic Information
Table 50. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Overview
Table 51. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Arbutus Biopharma (Tekmira) Business Overview
Table 53. Arbutus Biopharma (Tekmira) RNAi for Therapeutic SWOT Analysis
Table 54. Arbutus Biopharma (Tekmira) Recent Developments
Table 55. Arrowhead RNAi for Therapeutic Basic Information
Table 56. Arrowhead RNAi for Therapeutic Product Overview
Table 57. Arrowhead RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Arrowhead RNAi for Therapeutic SWOT Analysis
Table 59. Arrowhead Business Overview
Table 60. Arrowhead Recent Developments
Table 61. Dicerna Pharmaceuticals RNAi for Therapeutic Basic Information
Table 62. Dicerna Pharmaceuticals RNAi for Therapeutic Product Overview
Table 63. Dicerna Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dicerna Pharmaceuticals Business Overview
Table 65. Dicerna Pharmaceuticals Recent Developments
Table 66. Mirna Therapeutics RNAi for Therapeutic Basic Information
Table 67. Mirna Therapeutics RNAi for Therapeutic Product Overview
Table 68. Mirna Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mirna Therapeutics Business Overview
Table 70. Mirna Therapeutics Recent Developments
Table 71. Quark Pharmaceuticals RNAi for Therapeutic Basic Information
Table 72. Quark Pharmaceuticals RNAi for Therapeutic Product Overview
Table 73. Quark Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Quark Pharmaceuticals Business Overview
Table 75. Quark Pharmaceuticals Recent Developments
Table 76. RXi Pharmaceuticals RNAi for Therapeutic Basic Information
Table 77. RXi Pharmaceuticals RNAi for Therapeutic Product Overview
Table 78. RXi Pharmaceuticals RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. RXi Pharmaceuticals Business Overview
Table 80. RXi Pharmaceuticals Recent Developments
Table 81. Silence Therapeutics RNAi for Therapeutic Basic Information
Table 82. Silence Therapeutics RNAi for Therapeutic Product Overview
Table 83. Silence Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Silence Therapeutics Business Overview
Table 85. Silence Therapeutics Recent Developments
Table 86. Benitec Biopharma RNAi for Therapeutic Basic Information
Table 87. Benitec Biopharma RNAi for Therapeutic Product Overview
Table 88. Benitec Biopharma RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Benitec Biopharma Business Overview
Table 90. Benitec Biopharma Recent Developments
Table 91. miRagen Therapeutics RNAi for Therapeutic Basic Information
Table 92. miRagen Therapeutics RNAi for Therapeutic Product Overview
Table 93. miRagen Therapeutics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. miRagen Therapeutics Business Overview
Table 95. miRagen Therapeutics Recent Developments
Table 96. Sylentis RNAi for Therapeutic Basic Information
Table 97. Sylentis RNAi for Therapeutic Product Overview
Table 98. Sylentis RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sylentis Business Overview
Table 100. Sylentis Recent Developments
Table 101. Gradalis RNAi for Therapeutic Basic Information
Table 102. Gradalis RNAi for Therapeutic Product Overview
Table 103. Gradalis RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Gradalis Business Overview
Table 105. Gradalis Recent Developments
Table 106. Sirnaomics RNAi for Therapeutic Basic Information
Table 107. Sirnaomics RNAi for Therapeutic Product Overview
Table 108. Sirnaomics RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sirnaomics Business Overview
Table 110. Sirnaomics Recent Developments
Table 111. Silenseed RNAi for Therapeutic Basic Information
Table 112. Silenseed RNAi for Therapeutic Product Overview
Table 113. Silenseed RNAi for Therapeutic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Silenseed Business Overview
Table 115. Silenseed Recent Developments
Table 116. Global RNAi for Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global RNAi for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific RNAi for Therapeutic Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific RNAi for Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America RNAi for Therapeutic Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa RNAi for Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa RNAi for Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global RNAi for Therapeutic Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global RNAi for Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global RNAi for Therapeutic Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global RNAi for Therapeutic Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global RNAi for Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of RNAi for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNAi for Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global RNAi for Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global RNAi for Therapeutic Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNAi for Therapeutic Market Size by Country (M USD)
Figure 11. RNAi for Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global RNAi for Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNAi for Therapeutic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNAi for Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNAi for Therapeutic Market Share by Type
Figure 18. Sales Market Share of RNAi for Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of RNAi for Therapeutic by Type in 2023
Figure 20. Market Size Share of RNAi for Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of RNAi for Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNAi for Therapeutic Market Share by Application
Figure 24. Global RNAi for Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global RNAi for Therapeutic Sales Market Share by Application in 2023
Figure 26. Global RNAi for Therapeutic Market Share by Application (2019-2024)
Figure 27. Global RNAi for Therapeutic Market Share by Application in 2023
Figure 28. Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNAi for Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada RNAi for Therapeutic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico RNAi for Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific RNAi for Therapeutic Sales Market Share by Region in 2023
Figure 44. China RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 50. South America RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa RNAi for Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global RNAi for Therapeutic Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global RNAi for Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNAi for Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNAi for Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global RNAi for Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global RNAi for Therapeutic Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of RNAi for Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNAi for Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global RNAi for Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global RNAi for Therapeutic Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNAi for Therapeutic Market Size by Country (M USD)
Figure 11. RNAi for Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global RNAi for Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNAi for Therapeutic Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNAi for Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNAi for Therapeutic Market Share by Type
Figure 18. Sales Market Share of RNAi for Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of RNAi for Therapeutic by Type in 2023
Figure 20. Market Size Share of RNAi for Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of RNAi for Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNAi for Therapeutic Market Share by Application
Figure 24. Global RNAi for Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global RNAi for Therapeutic Sales Market Share by Application in 2023
Figure 26. Global RNAi for Therapeutic Market Share by Application (2019-2024)
Figure 27. Global RNAi for Therapeutic Market Share by Application in 2023
Figure 28. Global RNAi for Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global RNAi for Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada RNAi for Therapeutic Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico RNAi for Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 43. Asia Pacific RNAi for Therapeutic Sales Market Share by Region in 2023
Figure 44. China RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 50. South America RNAi for Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa RNAi for Therapeutic Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa RNAi for Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa RNAi for Therapeutic Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global RNAi for Therapeutic Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global RNAi for Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global RNAi for Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global RNAi for Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global RNAi for Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global RNAi for Therapeutic Market Share Forecast by Application (2025-2030)
